313 related articles for article (PubMed ID: 34468690)
1. Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement.
Massey PR; Schmults CD; Li SJ; Arron ST; Asgari MM; Bouwes Bavinck JN; Billingsley E; Blalock TW; Blasdale K; Carroll BT; Carucci JA; Chong AH; Christensen SR; Chung CL; DeSimone JA; Ducroux E; Escutia-Muñoz B; Ferrándiz-Pulido C; Fox MC; Genders RE; Geusau A; Gjersvik P; Hanlon AM; Olasz Harken EB; Hofbauer GFL; Hopkins RS; Leitenberger JJ; Loss MJ; Del Marmol V; Mascaró JM; Myers SA; Nguyen BT; Oliveira WRP; Otley CC; Proby CM; Rácz E; Ruiz-Salas V; Samie FH; Seçkin D; Shah SN; Shin TM; Shumack SP; Soon SL; Stasko T; Zavattaro E; Zeitouni NC; Zwald FO; Harwood CA; Jambusaria-Pahlajani A
JAMA Dermatol; 2021 Oct; 157(10):1219-1226. PubMed ID: 34468690
[TBL] [Abstract][Full Text] [Related]
2. Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
Hasan ZU; Ahmed I; Matin RN; Homer V; Lear JT; Ismail F; Whitmarsh T; Green AC; Thomson J; Milligan A; Hogan S; Van-de-Velde V; Mitchell-Worsford L; Kentley J; Gaunt C; Jefferson-Hulme Y; Bowden SJ; Gaunt P; Wheatley K; Proby CM; Harwood CA
Br J Dermatol; 2022 Sep; 187(3):324-337. PubMed ID: 34988975
[TBL] [Abstract][Full Text] [Related]
3. Skin Cancer Development Is Strongly Associated with Actinic Keratosis in Solid Organ Transplant Recipients: A Danish Cohort Study.
Wenande E; Togsverd-Bo K; Hastrup A; Lei U; Philipsen PA; Haedersdal M
Dermatology; 2023; 239(3):393-402. PubMed ID: 36731451
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
Schauder DM; Kim J; Nijhawan RI
JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
[TBL] [Abstract][Full Text] [Related]
5. Core Outcome Set for Actinic Keratosis Clinical Trials.
Reynolds KA; Schlessinger DI; Vasic J; Iyengar S; Qaseem Y; Behshad R; DeHoratius DM; Denes P; Drucker AM; Dzubow LM; Etzkorn JR; Harwood C; Kim JYS; Lee EH; Lissner GS; Marghoob AA; Matin RN; Mattox A; Mittal BB; Thomas JR; Zhou XA; Zloty D; Schmitt J; Kirkham J; Poon E; Sobanko JF; Cartee TV; Maher IA; Alam M
JAMA Dermatol; 2020 Mar; 156(3):326-333. PubMed ID: 31939999
[TBL] [Abstract][Full Text] [Related]
6. Dermatopathologic features of cutaneous squamous cell carcinoma and actinic keratosis: Consensus criteria and proposed reporting guidelines.
Christensen RE; Elston DM; Worley B; Dirr MA; Anvery N; Kang BY; Bahrami S; Brodell RT; Cerroni L; Elston C; Ferringer T; Hurley MY; Garton K; Lee JSS; Liu Y; Maize JC; McNiff JM; Rapini RP; Sangueza OP; Shea CR; Zhou C; Alam M
J Am Acad Dermatol; 2023 Jun; 88(6):1317-1325. PubMed ID: 36841336
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic options to decrease actinic keratosis and squamous cell carcinoma incidence and progression in solid organ transplant recipients: a practical approach.
Ritchie SA; Patel MJ; Miller SJ
Dermatol Surg; 2012 Oct; 38(10):1604-21. PubMed ID: 22646842
[TBL] [Abstract][Full Text] [Related]
8. Capecitabine for skin cancer prevention in solid organ transplant recipients.
Jirakulaporn T; Endrizzi B; Lindgren B; Mathew J; Lee PK; Dudek AZ
Clin Transplant; 2011; 25(4):541-8. PubMed ID: 21050273
[TBL] [Abstract][Full Text] [Related]
9. Actinic Keratosis in Solid Organ Transplant Recipients: A Medical Literature Review.
Morelló Vicente A; Oteiza Rius I; Aguado Gil L
Actas Dermosifiliogr; 2024 Apr; 115(4):368-373. PubMed ID: 37925069
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous squamous cell carcinoma in the organ transplant recipient.
Bibee K; Swartz A; Sridharan S; Kurten CHL; Wessel CB; Skinner H; Zandberg DP
Oral Oncol; 2020 Apr; 103():104562. PubMed ID: 32065978
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses.
Tee LY; Sultana R; Tam SYC; Oh CC
J Am Acad Dermatol; 2021 Feb; 84(2):528-530. PubMed ID: 32387631
[No Abstract] [Full Text] [Related]
12. Cumulative incidence and risk factors for cutaneous squamous cell carcinoma metastases in organ transplant recipients: The Skin Care in Organ Transplant Patients in Europe-International Transplant Skin Cancer Collaborative metastases study, a prospective multicenter study.
de Jong E; Genders R; Harwood CA; Green AC; Plasmeijer EI; Proby C; Geissler E; Ferrándiz-Pulido C; Ducroux E; Euvrard S; Geusau A; Jahn-Bassler K; Borik-Heil L; Rácz E; Nägeli M; Hofbauer GFL; Piaserico S; Russo I; Mackintosh L; Borges-Costa J; Angeliki-Gkini M; Zavattaro E; Savoia P; Imko-Walszuk B; Dębska-Slizień A; Garmyn M; van Kelst S; Ricar J; Cetkovska P; Matin R; Güleç AT; Seçkin D; Anene CA; Oliveira WRP; Rademaker M; Goeman J; van Geloven N; Ruiz E; Murad F; Karn E; Schmults CD; Bouwes Bavinck JN
J Am Acad Dermatol; 2024 Jun; 90(6):1200-1209. PubMed ID: 38301923
[TBL] [Abstract][Full Text] [Related]
13. Use of Topical and Systemic Retinoids in Solid Organ Transplant Recipients: Update and Review of the Current Literature.
Herold M; Good AJ; Nielson CB; Longo MI
Dermatol Surg; 2019 Dec; 45(12):1442-1449. PubMed ID: 31403546
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients.
Cheng JY; Li FY; Ko CJ; Colegio OR
JAMA Dermatol; 2018 Jan; 154(1):60-66. PubMed ID: 29167858
[TBL] [Abstract][Full Text] [Related]
15. Local interventions for actinic keratosis in organ transplant recipients: a systematic review.
Heppt MV; Steeb T; Niesert AC; Zacher M; Leiter U; Garbe C; Berking C
Br J Dermatol; 2019 Jan; 180(1):43-50. PubMed ID: 30188570
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
Allen NC; Martin AJ; Snaidr VA; Eggins R; Chong AH; Fernandéz-Peñas P; Gin D; Sidhu S; Paddon VL; Banney LA; Lim A; Upjohn E; Schaider H; Ganhewa AD; Nguyen J; McKenzie CA; Prakash S; McLean C; Lochhead A; Ibbetson J; Dettrick A; Landgren A; Allnutt KJ; Allison C; Davenport RB; Mumford BP; Wong B; Stagg B; Tedman A; Gribbin H; Edwards HA; De Rosa N; Stewart T; Doolan BJ; Kok Y; Simpson K; Low ZM; Kovitwanichkanont T; Scolyer RA; Dhillon HM; Vardy JL; Chadban SJ; Bowen DG; Chen AC; Damian DL
N Engl J Med; 2023 Mar; 388(9):804-812. PubMed ID: 36856616
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy for the prevention and treatment of actinic keratosis/squamous cell carcinoma in solid organ transplant recipients: a systematic review and meta-analysis.
Liew YCC; De Souza NNA; Sultana RG; Oh CC
J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):251-259. PubMed ID: 31394005
[TBL] [Abstract][Full Text] [Related]
18. Keratinocyte cancer and its precursors in organ transplant patients.
Jenni D; Hofbauer GF
Curr Probl Dermatol; 2015; 46():49-57. PubMed ID: 25561206
[TBL] [Abstract][Full Text] [Related]
19. Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis: A Secondary Analysis of a Randomized Clinical Trial.
Ahmady S; Jansen MHE; Nelemans PJ; Kessels JPHM; Arits AHMM; de Rooij MJM; Essers BAB; Quaedvlieg PJF; Kelleners-Smeets NWJ; Mosterd K
JAMA Dermatol; 2022 Jun; 158(6):634-640. PubMed ID: 35475852
[TBL] [Abstract][Full Text] [Related]
20. [Organ transplant recipients need intensive control and treatment of skin cancer].
Togsverd-Bo K; Sørensen SS; Hædersdal M
Ugeskr Laeger; 2013 May; 175(20):1408-11. PubMed ID: 23663395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]